Literature DB >> 27633129

Emerging Concepts Linking Obesity with the Hallmarks of Cancer.

Claire L Donohoe1, Joanne Lysaght1, Jacintha O'Sullivan1, John V Reynolds2.   

Abstract

There is compelling epidemiological evidence linking obesity to many tumours; however, the molecular mechanisms fuelling this association are not clearly understood. Emerging evidence links changes in the tumour microenvironment with the obese state, and murine and human studies highlight the relevance of adipose stromal cells (ASCs), including immune cells, both at remote fat depots, such as the omentum, as well as in peritumoural tissue. These obesity-associated changes have been implicated in several hallmarks of cancer, including the chronic inflammatory state and associated cell signalling, epithelial-to-mesenchymal transition (EMT), tumour-related fibrosis, angiogenesis, and genomic instability. Here, we present a summary of developments over the past 5 years, with particular focus on the tumour microenvironment in the obese state.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  cancer; cellular instability; inflammation; microenvironment; obesity

Mesh:

Year:  2016        PMID: 27633129     DOI: 10.1016/j.tem.2016.08.004

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  47 in total

Review 1.  Considerations for dosing immunoglobulin in obese patients.

Authors:  J P Hodkinson
Journal:  Clin Exp Immunol       Date:  2017-04-17       Impact factor: 4.330

2.  The macroenviromental control of cancer metabolism by p62.

Authors:  Jianfeng Huang; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cell Cycle       Date:  2018-09-20       Impact factor: 4.534

Review 3.  Cancer Cells Don't Live Alone: Metabolic Communication within Tumor Microenvironments.

Authors:  Fuming Li; M Celeste Simon
Journal:  Dev Cell       Date:  2020-07-07       Impact factor: 12.270

4.  Association between Dietary Energy Density and Obesity-Associated Cancer: Results from the Women's Health Initiative.

Authors:  Cynthia A Thomson; Tracy E Crane; David O Garcia; Betsy C Wertheim; Melanie Hingle; Linda Snetselaar; Mridul Datta; Thomas Rohan; Erin LeBlanc; Rowan T Chlebowski; Lihong Qi
Journal:  J Acad Nutr Diet       Date:  2017-08-17       Impact factor: 4.910

Review 5.  The immune remodel: Weight loss-mediated inflammatory changes to obesity.

Authors:  Charles L Phillips; Bernadette E Grayson
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-19

6.  Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.

Authors:  Masayuki Nagahashi; Akimitsu Yamada; Eriko Katsuta; Tomoyoshi Aoyagi; Wei-Ching Huang; Krista P Terracina; Nitai C Hait; Jeremy C Allegood; Junko Tsuchida; Kizuki Yuza; Masato Nakajima; Manabu Abe; Kenji Sakimura; Sheldon Milstien; Toshifumi Wakai; Sarah Spiegel; Kazuaki Takabe
Journal:  Cancer Res       Date:  2018-01-19       Impact factor: 12.701

Review 7.  Myeloid derived-suppressor cells: their role in cancer and obesity.

Authors:  Suzanne Ostrand-Rosenberg
Journal:  Curr Opin Immunol       Date:  2018-03-13       Impact factor: 7.486

8.  Therapeutic Time-restricted Feeding Reduces Renal Tumor Bioluminescence in Mice but Fails to Improve Anti-CTLA-4 Efficacy.

Authors:  William J Turbitt; Rachael M Orlandella; Justin T Gibson; Courtney M Peterson; Lyse A Norian
Journal:  Anticancer Res       Date:  2020-10       Impact factor: 2.480

Review 9.  Obesity and CD8 T cell metabolism: Implications for anti-tumor immunity and cancer immunotherapy outcomes.

Authors:  William J Turbitt; Claire Buchta Rosean; K Scott Weber; Lyse A Norian
Journal:  Immunol Rev       Date:  2020-03-10       Impact factor: 12.988

Review 10.  Translating Mechanism-Based Strategies to Break the Obesity-Cancer Link: A Narrative Review.

Authors:  Laura A Smith; Ciara H O'Flanagan; Laura W Bowers; Emma H Allott; Stephen D Hursting
Journal:  J Acad Nutr Diet       Date:  2018-04       Impact factor: 4.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.